Inogen revenue falls, but Q2 earnings beat analyst estimates
The COVID-19 pandemic continued to cut into Inogen’s revenue, as new physician referrals and patient mobility declined during a quarter usually marked by increased patient travel and demand. Revenue fell nearly 30 percent in the second quarter to $71.7 million, missing average analyst estimates, and net income of $2.7 million was down from $9.9 million Read More →
Read More →
Merger comes at a healthy time for Teladoc
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Saalex, AeroVironment help NASA get to Mars with morning Perseverance launch
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →EVMatch of Santa Barbara wins prestigious $25,000 climate prize
Santa Barbara electric vehicle infrastructure platform EVmatch took home a prestigious award on July 27 for its climate efforts, including a $25,000 prize. The startup, which connects EV drivers with residential and commercial charging stations, was among 10 winners of the 2020 Keeling Curve Prize. “These projects—like our former winners—were vetted by top climate experts Read More →
Read More →Teledyne stock climbs as Q2 earnings beat analyst estimates
Second-quarter sales for Thousand Oaks-based Teledyne Technologies dipped 5 percent to $743.3 million, and net income beat analyst estimates, sending the stock up 2.5 percent in early trading. Net income fell around 10 percent compared to the previous year’s second quarter to $93.7 million, or $2.48 per share, squarely beating analyst predictions of around $2 Read More →
Read More →Amgen puts $421M into BeiGene
Thousand Oaks biotech giant Amgen has upped its investment in Chinese oncology research firm BeiGene by $421 million. Amgen’s new investment, announced July 13, will allow the company maintain its ownership interest in BeiGene at 20.3 percent following a direct offering by the Chinese firm. Amgen shares rose more than 1 percent following the news Read More →
Read More →Making moves: Acquisitions help Santa Barbara’s Movegreen grow
Santa Barbara eco-friendly moving company Movegreen is working to claim more coastline, with two acquisitions that give it a foothold in Los Angeles and bridge its operations from Ventura to Orange County. The company is also in the final days of acquiring an expanded facility in Oxnard to serve as its new flagship, as historically Read More →
Read More →
